Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 22 | 2023 | 1962 | 1.900 |
Why?
|
| Brain | 22 | 2023 | 1560 | 1.550 |
Why?
|
| Gene Regulatory Networks | 6 | 2020 | 29 | 1.410 |
Why?
|
| Transcriptome | 8 | 2023 | 74 | 1.130 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 128 | 1.120 |
Why?
|
| Algorithms | 4 | 2023 | 347 | 1.090 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 1017 | 1.020 |
Why?
|
| Proteomics | 5 | 2022 | 85 | 1.020 |
Why?
|
| Proteome | 3 | 2022 | 38 | 0.960 |
Why?
|
| RNA, Messenger | 3 | 2022 | 284 | 0.940 |
Why?
|
| Cluster Analysis | 2 | 2023 | 39 | 0.730 |
Why?
|
| Dementia | 2 | 2022 | 532 | 0.650 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 262 | 0.530 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 264 | 0.530 |
Why?
|
| Models, Neurological | 1 | 2016 | 24 | 0.530 |
Why?
|
| Nerve Net | 1 | 2016 | 31 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 351 | 0.510 |
Why?
|
| Models, Theoretical | 1 | 2015 | 76 | 0.490 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 100 | 0.480 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.470 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.470 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.470 |
Why?
|
| Humans | 39 | 2023 | 25692 | 0.460 |
Why?
|
| Microglia | 5 | 2023 | 133 | 0.420 |
Why?
|
| Quantitative Trait Loci | 4 | 2021 | 39 | 0.420 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 110 | 0.390 |
Why?
|
| Aging | 6 | 2023 | 1429 | 0.370 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 155 | 0.370 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 26 | 0.360 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 87 | 0.350 |
Why?
|
| Hormones | 1 | 2010 | 9 | 0.350 |
Why?
|
| Aged, 80 and over | 13 | 2022 | 4459 | 0.340 |
Why?
|
| Cognition | 5 | 2021 | 1265 | 0.320 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 75 | 0.310 |
Why?
|
| Gene Expression | 4 | 2023 | 182 | 0.300 |
Why?
|
| Aged | 15 | 2023 | 8501 | 0.290 |
Why?
|
| DNA Methylation | 3 | 2022 | 139 | 0.290 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 244 | 0.290 |
Why?
|
| Amyloid beta-Peptides | 5 | 2021 | 315 | 0.290 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 51 | 0.270 |
Why?
|
| Male | 18 | 2022 | 13917 | 0.270 |
Why?
|
| Genome, Human | 2 | 2017 | 36 | 0.260 |
Why?
|
| Motor Activity | 2 | 2019 | 304 | 0.260 |
Why?
|
| Female | 17 | 2022 | 14273 | 0.260 |
Why?
|
| Phenotype | 4 | 2023 | 292 | 0.250 |
Why?
|
| Genotype | 3 | 2019 | 326 | 0.220 |
Why?
|
| Benchmarking | 1 | 2023 | 37 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 37 | 0.210 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 23 | 0.200 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 18 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 145 | 0.200 |
Why?
|
| Mutation | 2 | 2014 | 325 | 0.200 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 82 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 19 | 0.200 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 38 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.190 |
Why?
|
| Astrocytes | 2 | 2020 | 141 | 0.190 |
Why?
|
| Neurons | 4 | 2021 | 315 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 19 | 0.190 |
Why?
|
| Models, Genetic | 3 | 2020 | 30 | 0.180 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 182 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 104 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2021 | 82 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 88 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 36 | 0.170 |
Why?
|
| Autopsy | 5 | 2019 | 313 | 0.170 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 8 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2019 | 15 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 201 | 0.170 |
Why?
|
| Animals | 6 | 2020 | 3510 | 0.170 |
Why?
|
| Histones | 1 | 2019 | 27 | 0.170 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| Independent Living | 2 | 2019 | 294 | 0.160 |
Why?
|
| Schizophrenia | 3 | 2018 | 62 | 0.160 |
Why?
|
| Seasons | 1 | 2018 | 23 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Cohort Studies | 6 | 2019 | 1781 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 108 | 0.150 |
Why?
|
| Haplotypes | 1 | 2017 | 45 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 71 | 0.140 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 17 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 113 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 261 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 171 | 0.130 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.120 |
Why?
|
| Exercise | 1 | 2019 | 422 | 0.120 |
Why?
|
| tau Proteins | 3 | 2021 | 219 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 17 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 13 | 0.120 |
Why?
|
| Gait | 1 | 2018 | 350 | 0.120 |
Why?
|
| Mitochondria | 1 | 2014 | 62 | 0.120 |
Why?
|
| Risk Factors | 5 | 2019 | 2224 | 0.120 |
Why?
|
| Fibromyalgia | 1 | 2014 | 26 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1176 | 0.110 |
Why?
|
| Behavior | 1 | 2013 | 22 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 27 | 0.110 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 21 | 0.100 |
Why?
|
| Amygdala | 2 | 2010 | 42 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 66 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 249 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 1345 | 0.100 |
Why?
|
| Linear Models | 3 | 2018 | 231 | 0.100 |
Why?
|
| Gene Order | 1 | 2010 | 4 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1300 | 0.090 |
Why?
|
| Myelin Sheath | 1 | 2010 | 22 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2010 | 43 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 65 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 341 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 259 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 65 | 0.080 |
Why?
|
| Biomarkers | 2 | 2020 | 554 | 0.070 |
Why?
|
| Hippocampus | 2 | 2019 | 262 | 0.070 |
Why?
|
| Species Specificity | 2 | 2020 | 37 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 39 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 11 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 8 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 90 | 0.060 |
Why?
|
| DNA | 1 | 2023 | 95 | 0.060 |
Why?
|
| Organ Size | 1 | 2023 | 103 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 584 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 97 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 36 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 190 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 3 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 19 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 37 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 25 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 42 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 646 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 2 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 5 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 217 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 13 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 94 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 532 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 138 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 15 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 8403 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 12 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 37 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 79 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 111 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 44 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 78 | 0.040 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 101 | 0.040 |
Why?
|
| Epigenomics | 1 | 2017 | 13 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2017 | 31 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 366 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 140 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 93 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 9 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 100 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 195 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 183 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 96 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 329 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 869 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1633 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 7336 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 238 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 847 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 43 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 50 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 29 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 52 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 142 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 226 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 427 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 56 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1084 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 151 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1689 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 965 | 0.020 |
Why?
|
| United States | 1 | 2017 | 1943 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 776 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 17 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 52 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 98 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 84 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 403 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 211 | 0.020 |
Why?
|